IHH Healthcare Bhd
KLSE:IHH
Intrinsic Value
IHH Healthcare Bhd.is an investment holding company, which engages in the provision of healthcare services. [ Read More ]
The intrinsic value of one IHH stock under the Base Case scenario is 6.65 MYR. Compared to the current market price of 6.3 MYR, IHH Healthcare Bhd is Undervalued by 5%.
Valuation Backtest
IHH Healthcare Bhd
Run backtest to discover the historical profit from buying and selling IHH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
IHH Healthcare Bhd
Current Assets | 6.7B |
Cash & Short-Term Investments | 2.7B |
Receivables | 3.1B |
Other Current Assets | 933.2m |
Non-Current Assets | 43.5B |
Long-Term Investments | 4.5B |
PP&E | 20.5B |
Intangibles | 17.3B |
Other Non-Current Assets | 1.2B |
Current Liabilities | 7.5B |
Accounts Payable | 5B |
Accrued Liabilities | 158.4m |
Short-Term Debt | 77.9m |
Other Current Liabilities | 2.3B |
Non-Current Liabilities | 13.6B |
Long-Term Debt | 8.1B |
Other Non-Current Liabilities | 5.6B |
Earnings Waterfall
IHH Healthcare Bhd
Revenue
|
20.9B
MYR
|
Cost of Revenue
|
-6.2B
MYR
|
Gross Profit
|
14.7B
MYR
|
Operating Expenses
|
-10.5B
MYR
|
Operating Income
|
4.2B
MYR
|
Other Expenses
|
-1.2B
MYR
|
Net Income
|
3B
MYR
|
Free Cash Flow Analysis
IHH Healthcare Bhd
IHH Profitability Score
Profitability Due Diligence
IHH Healthcare Bhd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
IHH Healthcare Bhd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
IHH Solvency Score
Solvency Due Diligence
IHH Healthcare Bhd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
IHH Healthcare Bhd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
IHH Price Targets Summary
IHH Healthcare Bhd
According to Wall Street analysts, the average 1-year price target for IHH is 7.27 MYR with a low forecast of 6.46 MYR and a high forecast of 8.27 MYR.
Shareholder Return
IHH Price
IHH Healthcare Bhd
Average Annual Return | 3.8% |
Standard Deviation of Annual Returns | 15.55% |
Max Drawdown | -24% |
Market Capitalization | 55.5B MYR |
Shares Outstanding | 8 806 989 824 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
IHH Healthcare Bhd.is an investment holding company, which engages in the provision of healthcare services. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2012-04-02. The firm manages a portfolio of trusted healthcare brands, such as Acibadem, Mount Elizabeth, Prince Court, Gleneagles, Fortis, Pantai, Parkway and IMU in its key markets of Malaysia, Singapore, Turkey, India and Greater China (including Hong Kong). The firm operates through five segments: Parkway Pantai, which is a hospital operator and healthcare service provider in Asia; Acibadem Holdings, which is a hospital operator and healthcare service provider in Central Eastern Europe, the Middle East and North Africa and investment holding companies owning Acibadem Saglik Yatirimlari Holding A.S. (ASYH); IMU Health, which is an education service provider in Malaysia; PLife REIT, which is a real estate investment trust, and others segment, which includes the corporate office. The firm operates approximately 80 hospitals in over 10 countries.
Contact
IPO
Employees
Officers
The intrinsic value of one IHH stock under the Base Case scenario is 6.65 MYR.
Compared to the current market price of 6.3 MYR, IHH Healthcare Bhd is Undervalued by 5%.